Global Injectable Anticoagulants Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 88

Published Date: 29 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Injectable Anticoagulants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Injectable Anticoagulants market size is estimated to be worth US$ 6860.5 million in 2021 and is forecast to a readjusted size of USD 9887 million by 2028 with a CAGR of 5.4% during review period. VTE accounting for  % of the Injectable Anticoagulants global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While LMWH segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Injectable Anticoagulants include Sanofi, Genentech (Roche), Boehringer Ingelheim, Aspen, and Pfizer, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Injectable Anticoagulants market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    LMWH
    Unfractionated Heparin
    Fibrinolytics
    Others

Market segment by Application, can be divided into
    VTE
    ACS/MI
    AF
    Others

Market segment by players, this report covers
    Sanofi
    Genentech (Roche)
    Boehringer Ingelheim
    Aspen
    Pfizer
    Hepalink
    King-friend
    CSBIO
    Amphastar Pharmaceuticals

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Injectable Anticoagulants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Injectable Anticoagulants, with revenue, gross margin and global market share of Injectable Anticoagulants from 2019 to 2022.
Chapter 3, the Injectable Anticoagulants competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Injectable Anticoagulants market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Injectable Anticoagulants research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Injectable Anticoagulants
    1.2 Classification of Injectable Anticoagulants by Type
        1.2.1 Overview: Global Injectable Anticoagulants Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Injectable Anticoagulants Revenue Market Share by Type in 2021
        1.2.3 LMWH
        1.2.4 Unfractionated Heparin
        1.2.5 Fibrinolytics
        1.2.6 Others
    1.3 Global Injectable Anticoagulants Market by Application
        1.3.1 Overview: Global Injectable Anticoagulants Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 VTE
        1.3.3 ACS/MI
        1.3.4 AF
        1.3.5 Others
    1.4 Global Injectable Anticoagulants Market Size & Forecast
    1.5 Global Injectable Anticoagulants Market Size and Forecast by Region
        1.5.1 Global Injectable Anticoagulants Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Injectable Anticoagulants Market Size by Region, (2017-2022)
        1.5.3 North America Injectable Anticoagulants Market Size and Prospect (2017-2028)
        1.5.4 Europe Injectable Anticoagulants Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Injectable Anticoagulants Market Size and Prospect (2017-2028)
        1.5.6 South America Injectable Anticoagulants Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Injectable Anticoagulants Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Injectable Anticoagulants Market Drivers
        1.6.2 Injectable Anticoagulants Market Restraints
        1.6.3 Injectable Anticoagulants Trends Analysis

2 Company Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Injectable Anticoagulants Product and Solutions
        2.1.4 Sanofi Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Sanofi Recent Developments and Future Plans
    2.2 Genentech (Roche)
        2.2.1 Genentech (Roche) Details
        2.2.2 Genentech (Roche) Major Business
        2.2.3 Genentech (Roche) Injectable Anticoagulants Product and Solutions
        2.2.4 Genentech (Roche) Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Genentech (Roche) Recent Developments and Future Plans
    2.3 Boehringer Ingelheim
        2.3.1 Boehringer Ingelheim Details
        2.3.2 Boehringer Ingelheim Major Business
        2.3.3 Boehringer Ingelheim Injectable Anticoagulants Product and Solutions
        2.3.4 Boehringer Ingelheim Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.4 Aspen
        2.4.1 Aspen Details
        2.4.2 Aspen Major Business
        2.4.3 Aspen Injectable Anticoagulants Product and Solutions
        2.4.4 Aspen Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Aspen Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Injectable Anticoagulants Product and Solutions
        2.5.4 Pfizer Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Hepalink
        2.6.1 Hepalink Details
        2.6.2 Hepalink Major Business
        2.6.3 Hepalink Injectable Anticoagulants Product and Solutions
        2.6.4 Hepalink Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Hepalink Recent Developments and Future Plans
    2.7 King-friend
        2.7.1 King-friend Details
        2.7.2 King-friend Major Business
        2.7.3 King-friend Injectable Anticoagulants Product and Solutions
        2.7.4 King-friend Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 King-friend Recent Developments and Future Plans
    2.8 CSBIO
        2.8.1 CSBIO Details
        2.8.2 CSBIO Major Business
        2.8.3 CSBIO Injectable Anticoagulants Product and Solutions
        2.8.4 CSBIO Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 CSBIO Recent Developments and Future Plans
    2.9 Amphastar Pharmaceuticals
        2.9.1 Amphastar Pharmaceuticals Details
        2.9.2 Amphastar Pharmaceuticals Major Business
        2.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Product and Solutions
        2.9.4 Amphastar Pharmaceuticals Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Amphastar Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Injectable Anticoagulants Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Injectable Anticoagulants Players Market Share in 2021
        3.2.2 Top 10 Injectable Anticoagulants Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Injectable Anticoagulants Players Head Office, Products and Services Provided
    3.4 Injectable Anticoagulants Mergers & Acquisitions
    3.5 Injectable Anticoagulants New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Injectable Anticoagulants Revenue and Market Share by Type (2017-2022)
    4.2 Global Injectable Anticoagulants Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
    5.2 Global Injectable Anticoagulants Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Injectable Anticoagulants Revenue by Type (2017-2028)
    6.2 North America Injectable Anticoagulants Revenue by Application (2017-2028)
    6.3 North America Injectable Anticoagulants Market Size by Country
        6.3.1 North America Injectable Anticoagulants Revenue by Country (2017-2028)
        6.3.2 United States Injectable Anticoagulants Market Size and Forecast (2017-2028)
        6.3.3 Canada Injectable Anticoagulants Market Size and Forecast (2017-2028)
        6.3.4 Mexico Injectable Anticoagulants Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Injectable Anticoagulants Revenue by Type (2017-2028)
    7.2 Europe Injectable Anticoagulants Revenue by Application (2017-2028)
    7.3 Europe Injectable Anticoagulants Market Size by Country
        7.3.1 Europe Injectable Anticoagulants Revenue by Country (2017-2028)
        7.3.2 Germany Injectable Anticoagulants Market Size and Forecast (2017-2028)
        7.3.3 France Injectable Anticoagulants Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Injectable Anticoagulants Market Size and Forecast (2017-2028)
        7.3.5 Russia Injectable Anticoagulants Market Size and Forecast (2017-2028)
        7.3.6 Italy Injectable Anticoagulants Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Injectable Anticoagulants Revenue by Type (2017-2028)
    8.2 Asia-Pacific Injectable Anticoagulants Revenue by Application (2017-2028)
    8.3 Asia-Pacific Injectable Anticoagulants Market Size by Region
        8.3.1 Asia-Pacific Injectable Anticoagulants Revenue by Region (2017-2028)
        8.3.2 China Injectable Anticoagulants Market Size and Forecast (2017-2028)
        8.3.3 Japan Injectable Anticoagulants Market Size and Forecast (2017-2028)
        8.3.4 South Korea Injectable Anticoagulants Market Size and Forecast (2017-2028)
        8.3.5 India Injectable Anticoagulants Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Injectable Anticoagulants Market Size and Forecast (2017-2028)
        8.3.7 Australia Injectable Anticoagulants Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Injectable Anticoagulants Revenue by Type (2017-2028)
    9.2 South America Injectable Anticoagulants Revenue by Application (2017-2028)
    9.3 South America Injectable Anticoagulants Market Size by Country
        9.3.1 South America Injectable Anticoagulants Revenue by Country (2017-2028)
        9.3.2 Brazil Injectable Anticoagulants Market Size and Forecast (2017-2028)
        9.3.3 Argentina Injectable Anticoagulants Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Injectable Anticoagulants Revenue by Type (2017-2028)
    10.2 Middle East & Africa Injectable Anticoagulants Revenue by Application (2017-2028)
    10.3 Middle East & Africa Injectable Anticoagulants Market Size by Country
        10.3.1 Middle East & Africa Injectable Anticoagulants Revenue by Country (2017-2028)
        10.3.2 Turkey Injectable Anticoagulants Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Injectable Anticoagulants Market Size and Forecast (2017-2028)
        10.3.4 UAE Injectable Anticoagulants Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Injectable Anticoagulants Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Injectable Anticoagulants Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Injectable Anticoagulants Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Injectable Anticoagulants Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Injectable Anticoagulants Revenue Market Share by Region (2023-2028)
    Table 6. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 7. Sanofi Major Business
    Table 8. Sanofi Injectable Anticoagulants Product and Solutions
    Table 9. Sanofi Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Genentech (Roche) Corporate Information, Head Office, and Major Competitors
    Table 11. Genentech (Roche) Major Business
    Table 12. Genentech (Roche) Injectable Anticoagulants Product and Solutions
    Table 13. Genentech (Roche) Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
    Table 15. Boehringer Ingelheim Major Business
    Table 16. Boehringer Ingelheim Injectable Anticoagulants Product and Solutions
    Table 17. Boehringer Ingelheim Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Aspen Corporate Information, Head Office, and Major Competitors
    Table 19. Aspen Major Business
    Table 20. Aspen Injectable Anticoagulants Product and Solutions
    Table 21. Aspen Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 23. Pfizer Major Business
    Table 24. Pfizer Injectable Anticoagulants Product and Solutions
    Table 25. Pfizer Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Hepalink Corporate Information, Head Office, and Major Competitors
    Table 27. Hepalink Major Business
    Table 28. Hepalink Injectable Anticoagulants Product and Solutions
    Table 29. Hepalink Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. King-friend Corporate Information, Head Office, and Major Competitors
    Table 31. King-friend Major Business
    Table 32. King-friend Injectable Anticoagulants Product and Solutions
    Table 33. King-friend Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. CSBIO Corporate Information, Head Office, and Major Competitors
    Table 35. CSBIO Major Business
    Table 36. CSBIO Injectable Anticoagulants Product and Solutions
    Table 37. CSBIO Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Amphastar Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 39. Amphastar Pharmaceuticals Major Business
    Table 40. Amphastar Pharmaceuticals Injectable Anticoagulants Product and Solutions
    Table 41. Amphastar Pharmaceuticals Injectable Anticoagulants Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Global Injectable Anticoagulants Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 43. Global Injectable Anticoagulants Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 44. Breakdown of Injectable Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 45. Injectable Anticoagulants Players Head Office, Products and Services Provided
    Table 46. Injectable Anticoagulants Mergers & Acquisitions in the Past Five Years
    Table 47. Injectable Anticoagulants New Entrants and Expansion Plans
    Table 48. Global Injectable Anticoagulants Revenue (USD Million) by Type (2017-2022)
    Table 49. Global Injectable Anticoagulants Revenue Share by Type (2017-2022)
    Table 50. Global Injectable Anticoagulants Revenue Forecast by Type (2023-2028)
    Table 51. Global Injectable Anticoagulants Revenue by Application (2017-2022)
    Table 52. Global Injectable Anticoagulants Revenue Forecast by Application (2023-2028)
    Table 53. North America Injectable Anticoagulants Revenue by Type (2017-2022) & (USD Million)
    Table 54. North America Injectable Anticoagulants Revenue by Type (2023-2028) & (USD Million)
    Table 55. North America Injectable Anticoagulants Revenue by Application (2017-2022) & (USD Million)
    Table 56. North America Injectable Anticoagulants Revenue by Application (2023-2028) & (USD Million)
    Table 57. North America Injectable Anticoagulants Revenue by Country (2017-2022) & (USD Million)
    Table 58. North America Injectable Anticoagulants Revenue by Country (2023-2028) & (USD Million)
    Table 59. Europe Injectable Anticoagulants Revenue by Type (2017-2022) & (USD Million)
    Table 60. Europe Injectable Anticoagulants Revenue by Type (2023-2028) & (USD Million)
    Table 61. Europe Injectable Anticoagulants Revenue by Application (2017-2022) & (USD Million)
    Table 62. Europe Injectable Anticoagulants Revenue by Application (2023-2028) & (USD Million)
    Table 63. Europe Injectable Anticoagulants Revenue by Country (2017-2022) & (USD Million)
    Table 64. Europe Injectable Anticoagulants Revenue by Country (2023-2028) & (USD Million)
    Table 65. Asia-Pacific Injectable Anticoagulants Revenue by Type (2017-2022) & (USD Million)
    Table 66. Asia-Pacific Injectable Anticoagulants Revenue by Type (2023-2028) & (USD Million)
    Table 67. Asia-Pacific Injectable Anticoagulants Revenue by Application (2017-2022) & (USD Million)
    Table 68. Asia-Pacific Injectable Anticoagulants Revenue by Application (2023-2028) & (USD Million)
    Table 69. Asia-Pacific Injectable Anticoagulants Revenue by Region (2017-2022) & (USD Million)
    Table 70. Asia-Pacific Injectable Anticoagulants Revenue by Region (2023-2028) & (USD Million)
    Table 71. South America Injectable Anticoagulants Revenue by Type (2017-2022) & (USD Million)
    Table 72. South America Injectable Anticoagulants Revenue by Type (2023-2028) & (USD Million)
    Table 73. South America Injectable Anticoagulants Revenue by Application (2017-2022) & (USD Million)
    Table 74. South America Injectable Anticoagulants Revenue by Application (2023-2028) & (USD Million)
    Table 75. South America Injectable Anticoagulants Revenue by Country (2017-2022) & (USD Million)
    Table 76. South America Injectable Anticoagulants Revenue by Country (2023-2028) & (USD Million)
    Table 77. Middle East & Africa Injectable Anticoagulants Revenue by Type (2017-2022) & (USD Million)
    Table 78. Middle East & Africa Injectable Anticoagulants Revenue by Type (2023-2028) & (USD Million)
    Table 79. Middle East & Africa Injectable Anticoagulants Revenue by Application (2017-2022) & (USD Million)
    Table 80. Middle East & Africa Injectable Anticoagulants Revenue by Application (2023-2028) & (USD Million)
    Table 81. Middle East & Africa Injectable Anticoagulants Revenue by Country (2017-2022) & (USD Million)
    Table 82. Middle East & Africa Injectable Anticoagulants Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Injectable Anticoagulants Picture
    Figure 2. Global Injectable Anticoagulants Revenue Market Share by Type in 2021
    Figure 3. LMWH
    Figure 4. Unfractionated Heparin
    Figure 5. Fibrinolytics
    Figure 6. Others
    Figure 7. Injectable Anticoagulants Revenue Market Share by Application in 2021
    Figure 8. VTE Picture
    Figure 9. ACS/MI Picture
    Figure 10. AF Picture
    Figure 11. Others Picture
    Figure 12. Global Injectable Anticoagulants Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 13. Global Injectable Anticoagulants Revenue and Forecast (2017-2028) & (USD Million)
    Figure 14. Global Injectable Anticoagulants Revenue Market Share by Region (2017-2028)
    Figure 15. Global Injectable Anticoagulants Revenue Market Share by Region in 2021
    Figure 16. North America Injectable Anticoagulants Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Europe Injectable Anticoagulants Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Asia-Pacific Injectable Anticoagulants Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. South America Injectable Anticoagulants Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Middle East and Africa Injectable Anticoagulants Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Injectable Anticoagulants Market Drivers
    Figure 22. Injectable Anticoagulants Market Restraints
    Figure 23. Injectable Anticoagulants Market Trends
    Figure 24. Sanofi Recent Developments and Future Plans
    Figure 25. Genentech (Roche) Recent Developments and Future Plans
    Figure 26. Boehringer Ingelheim Recent Developments and Future Plans
    Figure 27. Aspen Recent Developments and Future Plans
    Figure 28. Pfizer Recent Developments and Future Plans
    Figure 29. Hepalink Recent Developments and Future Plans
    Figure 30. King-friend Recent Developments and Future Plans
    Figure 31. CSBIO Recent Developments and Future Plans
    Figure 32. Amphastar Pharmaceuticals Recent Developments and Future Plans
    Figure 33. Global Injectable Anticoagulants Revenue Share by Players in 2021
    Figure 34. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 35. Global Top 3 Players Injectable Anticoagulants Revenue Market Share in 2021
    Figure 36. Global Top 10 Players Injectable Anticoagulants Revenue Market Share in 2021
    Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 38. Global Injectable Anticoagulants Revenue Share by Type in 2021
    Figure 39. Global Injectable Anticoagulants Market Share Forecast by Type (2023-2028)
    Figure 40. Global Injectable Anticoagulants Revenue Share by Application in 2021
    Figure 41. Global Injectable Anticoagulants Market Share Forecast by Application (2023-2028)
    Figure 42. North America Injectable Anticoagulants Sales Market Share by Type (2017-2028)
    Figure 43. North America Injectable Anticoagulants Sales Market Share by Application (2017-2028)
    Figure 44. North America Injectable Anticoagulants Revenue Market Share by Country (2017-2028)
    Figure 45. United States Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 46. Canada Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Mexico Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Europe Injectable Anticoagulants Sales Market Share by Type (2017-2028)
    Figure 49. Europe Injectable Anticoagulants Sales Market Share by Application (2017-2028)
    Figure 50. Europe Injectable Anticoagulants Revenue Market Share by Country (2017-2028)
    Figure 51. Germany Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. France Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. United Kingdom Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Russia Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Italy Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Asia-Pacific Injectable Anticoagulants Sales Market Share by Type (2017-2028)
    Figure 57. Asia-Pacific Injectable Anticoagulants Sales Market Share by Application (2017-2028)
    Figure 58. Asia-Pacific Injectable Anticoagulants Revenue Market Share by Region (2017-2028)
    Figure 59. China Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Japan Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. South Korea Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. India Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Southeast Asia Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Australia Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. South America Injectable Anticoagulants Sales Market Share by Type (2017-2028)
    Figure 66. South America Injectable Anticoagulants Sales Market Share by Application (2017-2028)
    Figure 67. South America Injectable Anticoagulants Revenue Market Share by Country (2017-2028)
    Figure 68. Brazil Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Argentina Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Middle East and Africa Injectable Anticoagulants Sales Market Share by Type (2017-2028)
    Figure 71. Middle East and Africa Injectable Anticoagulants Sales Market Share by Application (2017-2028)
    Figure 72. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Country (2017-2028)
    Figure 73. Turkey Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. UAE Injectable Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
Genentech (Roche)
Boehringer Ingelheim
Aspen
Pfizer
Hepalink
King-friend
CSBIO
Amphastar Pharmaceuticals

Related Reports

Global Injectable Anticoagulants Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Injectable Anticoagulants Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 27 Jan 2021

date Pharma & Healthcare

The Injectable Anticoagulants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Injectable Anticoagulants Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Injectable Anticoagulants Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 05 Jun 2021

date Pharma & Healthcare

Global Injectable Anticoagulants Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Injectable Anticoagulants Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).

Global Injectable Anticoagulants Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Injectable Anticoagulants Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Injectable Anticoagulants market size was valued at USD 6268.4 million in 2023 and is forecast to a readjusted size of USD 7205.2 million by 2030 with a CAGR of 2.0% during review period.

Product Tags

injectable anticoagulants

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>